子宫内膜癌患者癌组织中PCNA和CD_(34)蛋白表达的实验研究

来源 :中国妇幼保健 | 被引量 : 0次 | 上传用户:ffdsfdsadsfafdsa
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的:探讨子宫内膜癌患者癌组织中PCNA和CD34蛋白的表达及意义。方法:选取子宫内膜癌手术患者120例,术后取手术切除的癌组织(实验组)及癌旁正常组织(对照组),采用ELISA法和实时荧光定量PCR法检测患者癌组织中PCNA和CD34蛋白的表达。结果:与对照组比较,实验组患者癌组织中PCNA、CD34的蛋白含量及m RNA水平均明显升高,差异有统计学意义(P<0.01);PCNA和CD34在组织中蛋白含量及m RNA水平均呈正相关性(r=0.608、P=0.037,r=0.576、P=0.029)。结论:子宫内膜癌患者癌组织中PCNA和CD34蛋白表达的升高,可能与子宫内膜癌的发生、发展有关,其作用机制有待于进一步研究。 Objective: To investigate the expression and significance of PCNA and CD34 protein in cancer tissue of patients with endometrial cancer. Methods: Totally 120 patients with endometrial carcinoma were selected for surgical resection of cancer tissue (experimental group) and adjacent normal tissue (control group). The levels of PCNA and PCNA were detected by ELISA and real-time fluorescence quantitative PCR CD34 protein expression. Results: Compared with the control group, the protein and mRNA levels of PCNA and CD34 in the experimental group were significantly increased (P <0.01). The protein and mRNA levels of PCNA and CD34 The levels were positively correlated (r = 0.608, P = 0.037, r = 0.576, P = 0.029). Conclusion: The increased expression of PCNA and CD34 protein in endometrial carcinoma may be related to the occurrence and development of endometrial carcinoma. The mechanism of action needs to be further studied.
其他文献
学位
背景目前,艾滋病仍是全球面临的重大公共卫生问题和社会问题,随着艾滋病母婴阻断方案的实施及技术的不断成熟,越来越多的HIV阳性妇女选择生育,然而,这些妇女所生子女是个比较特殊的群体,胎儿期暴露于HIV病毒及抗病毒药物,为提高母婴阻断成功率,出生后继续预防性服用抗病毒药物,他们的体格发育与智能发育是否受到负面影响,值得关注和研究。目的了解HIV阳性母亲的婴幼儿的生长发育水平,评价其营养状况及智能发育状